Company profile

Ticker
AGN
Exchange
CEO
Brenton L. Saunders
Employees
Incorporated in
Location
Fiscal year end
Former names
Actavis Ltd, Actavis plc
SEC CIK

AGN stock data

(
)

Calendar

7 May 20
11 Jul 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 4.35B 4.05B 4.09B 3.6B
Net income -317.2M -786.8M -1.76B -2.41B
Diluted EPS -0.97 -2.4 -5.37 -7.25
Net profit margin -7.29% -19.42% -43.01% -66.94%
Operating income -276.6M -596.6M -1.26B -2.31B
Net change in cash 1.27B -413.9M 862.9M -91.9M
Cash on hand 2.5B 1.24B 1.65B 788.5M
Cost of revenue 704M 639M 652.3M 497.8M
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 16.09B 15.79B 15.94B 14.57B
Net income -5.27B -5.1B -4.13B 14.97B
Diluted EPS -16.02 -15.26 -13.19 38.18
Net profit margin -32.76% -32.28% -25.88% 103%
Operating income -4.45B -6.25B -5.92B -1.83B
Net change in cash 1.62B -936.8M 93.2M 628M
Cash on hand 2.5B 880.4M 1.82B 1.72B
Cost of revenue 2.49B 2.19B 2.17B 1.86B

Financial data from Allergan earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
8 May 20 McDonnell Peter J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 6,352 0 0
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 16,532 0 0
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 471 0 26,080
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No 70.79 9,446 668.68K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No 73.14 3,691 269.96K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No 90.22 2,790 251.71K 0
8 May 20 William Meury RSU Sale back to company Dispose D No 0 25,201 0 0
8 May 20 William Meury Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 7,434 0 0
8 May 20 William Meury Performance Stock Units Ordinary Shares Sale back to company Dispose D No 0 26,506 0 0
8 May 20 William Meury Stock Options Ordinary Shares Sale back to company Dispose D No 196.16 12,304 2.41M 0
87.7% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 849 925 -8.2%
Opened positions 80 129 -38.0%
Closed positions 156 97 +60.8%
Increased positions 272 269 +1.1%
Reduced positions 362 380 -4.7%
13F shares
Current Prev Q Change
Total value 50.96B 55.35B -7.9%
Total shares 287.78M 289.36M -0.5%
Total puts 5.69M 9.7M -41.4%
Total calls 1.18M 3.32M -64.6%
Total put/call ratio 4.8 2.9 +65.7%
Largest owners
Shares Value Change
Vanguard 25.15M $4.45B +2.6%
BLK BlackRock 21.14M $3.74B +1.6%
STT State Street 13.7M $2.43B -4.9%
CS Credit Suisse 10.73M $1.9B +23.4%
Adage Capital Partners GP, L.L.C. 9.37M $1.66B +42.4%
Farallon Capital Management 9.3M $1.65B +16.4%
BAC Bank of America 8.43M $1.49B +10.7%
C Citigroup 7.93M $1.4B +34.7%
GS The Goldman Sachs Group, Inc. 7.49M $1.33B -1.1%
Renaissance Technologies 7.09M $1.26B +41.2%
Largest transactions
Shares Bought/sold Change
Norges Bank 0 -3.91M EXIT
Adage Capital Partners GP, L.L.C. 9.37M +2.79M +42.4%
Citadel Advisors 3.4M +2.27M +200.3%
Renaissance Technologies 7.09M +2.07M +41.2%
Paulson & Co. 602.13K -2.06M -77.4%
C Citigroup 7.93M +2.04M +34.7%
CS Credit Suisse 10.73M +2.04M +23.4%
Longview Partners 5.01M -1.9M -27.5%
N Price T Rowe Associates 721.67K -1.7M -70.2%
Pentwater Capital Management 1.69M +1.64M +3018.1%

Financial report summary

?
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: alpha, API, argument, Asia, AstraZeneca, autoimmune, behavior, biodegradable, broadest, built, buyer, Cadila, certainty, chain, composition, confirm, confirming, contamination, continent, Coolsculpting, CoolTone, Cream, cystic, declare, deliver, detailing, discontinuation, discontinued, distancing, Durysta, electronic, enrolling, environment, enzyme, Esthetique, evolve, exocrine, experienced, Gedeon, genericization, glaucoma, globe, half, home, hypertension, inability, indirectly, inhibitor, innovation, insufficiency, intracameral, intraocular, IOP, Ireland, Lab, Lazeo, LIBOR, lifetime, local, logistical, losing, medial, minute, mitigate, Nestle, OAG, ocular, OHT, outbreak, Pacific, pancreatic, pandemic, patient, pressure, rebate, recession, recovery, relationship, remotely, reply, Richter, satisfaction, Science, shelter, spent, spread, strain, susceptible, suspended, temporarily, Ubrelvy, unemployment, Viokace, Vital
Removed: absence, acceleration, acid, add, adjunctive, advancement, affirming, Akorn, Akron, Apotex, appellate, applied, Argentum, asserting, authorize, automatically, back, binding, BioMed, Biomedical, Body, bound, buy, calculate, calculated, capitalized, capitalizing, Center, centralized, certiorari, chosen, clarify, cloud, collateralization, collateralized, commonly, computing, concurrently, Contouring, contractually, conversion, correct, corrected, Corrupt, cumulative, delaying, Delzicol, denial, denying, Depressive, dermatology, determining, Deva, disgorgement, Disorder, dozen, Easement, enablement, enacted, enforceable, Envy, equaled, equipment, equitable, error, established, estate, Europe, exemption, exercised, expedient, explicitly, Famy, fiscal, fleet, fourth, Framework, gamma, GILTI, ground, Harbor, HD, higher, hosted, immunity, implementation, implicit, implicitly, improper, incorrectly, India, Influenced, InnoPharma, institute, instrument, intent, invalidity, inventorship, issuing, joinder, LA, land, lease, leasing, Legacy, legally, lessee, lessor, Lidoderm, LifeCell, limit, Low, mandatorily, mandatory, MDD, modified, modify, noncancelable, notification, offsetting, older, opening, option, orphan, ownership, package, pattern, Pennsylvania, pension, permission, pertaining, Pharmacal, pivotal, plant, Plastic, postretirement, practical, preferred, prepaid, preventing, privately, pronouncement, prospectively, purpose, qualify, Racketeer, rapastinel, rating, reaching, real, receptor, reclassification, reclassify, recognition, redeemed, refinancing, released, remove, renew, renewal, rental, Replacement, represented, requiring, residual, restitution, resurfacing, retinoic, retired, retrospective, retrospectively, revaluation, reversing, RORyt, ROU, SA, scaling, shortened, skin, Slayback, software, sovereign, standalone, statutory, stranded, substantive, substitute, Subtopic, suit, supplier, Surgery, suspension, Targeted, Taxed, TCJA, terminate, Therapy, threshold, topline, treble, tribal, TWi, Ubrogepant, unrelated, updated, USD, vendor, VI, Vitae, withdraw, withdrew, writ